RecruitingNot ApplicableNCT06114667

Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis

Nasal High Flow in Early Management of Patients Admitted to the Emergency Department for Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis : a Randomized Controlled Non Inferiority Study


Sponsor

University Hospital, Montpellier

Enrollment

174 participants

Start Date

Jun 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine whether nasal high flow is non inferior to non invasive ventilation (NIV) in the early treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and hypercapnic acidosis in the emergency department (ED). After obtaining informed consent, participants will be randomly assigned to receive either nasal high flow or non invasive ventilation (NIV, reference treatment) as respiratory support. Researchers will compare both respiratory support groups to see if their blood gas analysis and respiration return to normal ranges.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Ventilatory support via NIV and a medical device called Ventilatory support via nasal high flow for people with acute exacerbation of chronic obstructive pulmonary disease, hypercapnic acidosis, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVentilatory support via nasal high flow

Ventilatory support will be applied in 2h sessions and resumed as needed according to international guidelines for NIV treatment.

DEVICEVentilatory support via NIV

Ventilatory support will be applied in 2h sessions and resumed as needed according to international guidelines for NIV treatment.


Locations(3)

Montpellier University Hospital

Montpellier, Montepllier, France

Centre hospitalier universitaire de Nimes

Nîmes, France

Centre Hospitalier Universitaire de Poitiers

Poitiers, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06114667


Related Trials